Comparison of four alternative national universal anterior cruciate ligament injury prevention programme implementation strategies to reduce secondary future medical costs. Issue 4 (19th December 2016)

• Record Type: Journal Article
• Authors: Lewis, Dion A; Kirkbride, Brent; Vertullo, Christopher J; Gordon, Louisa; Comans, Tracy A
• Is Part Of: British journal of sports medicine. Volume 52:Issue 4(2018)
• Page Start: 277
• Page End: 282
• Publication Date: 2016-12-19
• Subjects: Anterior cruciate ligament -- Injury prevention -- Osteoarthritis -- Neuromuscular -- Public health; Sports medicine -- Periodicals; 617.1027
• DOI: 10.1136/bjsports-2016-096667
• Languages: English
• ISSNs: 0306-3674

Abstract

Abstract : Background/aim: Anterior cruciate ligament (ACL) injury is a common and devastating sporting injury. With or without ACL reconstruction, the risk of knee osteoarthritis (OA) and permanent disability later in life is markedly increased. While neuromuscular training programmes can prevent 50–80% of ACL injuries, no national implementation strategies exist in Australia. The aim of this study was to compare the ability of four alternative national universal ACL injury prevention programme implementation strategies to reduce future medical costs secondary to ACL injury. Methods: A Markov economic decision model was constructed to estimate the value in lifetime future medical costs prevented by implementing a national ACL prevention programme among four hypothetical cohorts: high-risk sport participants (HR) aged 12–25 years; HR 18–25 years; HR 12–17 years; all youths (ALL) 12–17 years. Results: Of the four programmes examined, the HR 12–25 programme provided the greatest value, averting US$693 of direct healthcare costs per person per lifetime or US$221 870 880 in total. Without training, 9.4% of this cohort will rupture their ACL and 16.8% will develop knee OA. Training prevents 3764 lifetime ACL ruptures per 100 000 individuals, a 40% reduction in ACL injuries. 842 lifetime cases of OA per 100 000 individuals and 584 TKRs per 100 000 are subsequently averted. Numbers needed to treat ranged from 27 for the HR 12–25 to 190 for the ALL 12–17. Conclusions: The HR 12–25 programme was the most effective implementation strategy. Estimation of the break-even cost of health expenditure savings will enable optimal future programme design, implementation and expenditure.